THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients With Advanced Pancreatic Cancer
Latest Information Update: 21 Apr 2025
At a glance
- Drugs Hydroxychloroquine (Primary) ; Trametinib (Primary)
- Indications Adenocarcinoma; Pancreatic ductal carcinoma
- Focus Adverse reactions
- Acronyms THREAD
Most Recent Events
- 16 Apr 2025 Planned End Date changed from 18 Jan 2026 to 1 Mar 2029.
- 16 Apr 2025 Status changed from recruiting to active, no longer recruiting.
- 24 Feb 2025 Planned primary completion date changed from 18 Jan 2025 to 1 Apr 2025.